In particular, one study examined muscle expressing a “nanodysferlin”, designed to be therapeutic [118], while another examined muscle expressing a small form of dysferlin encountered in a patient with only a mild form of dysferlinopathy [73,119]. The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.